易方达标普生物科技人民币C(012866)

动态评分: 6.09分

投资组合

报告日期 名称 比例
2021-12-31 ALX Oncology Holdings Inc 0.32%
2021-12-31 Krystal Biotech Inc 0.31%
2021-12-31 Radius Health Inc 0.31%
2021-12-31 Keros Therapeutics Inc 0.3%
2021-12-31 Gossamer Bio Inc 0.28%
2021-12-31 BioXcel Therapeutics Inc 0.27%
2021-12-31 Replimune Group Inc 0.26%
2021-12-31 VBI Vaccines Inc 0.26%
2021-12-31 iTeos Therapeutics Inc 0.25%
2021-12-31 CEL-SCI Corp 0.24%
2021-12-31 Inhibrx Inc 0.24%
2021-12-31 梅莎娜制药 0.24%
2021-12-31 Precigen Inc 0.24%
2021-12-31 Akebia Therapeutics Inc 0.23%
2021-12-31 BioAtla Inc 0.23%
2021-12-31 Eagle制药 0.23%
2021-12-31 4D Molecular Therapeutics Inc 0.23%
2021-12-31 IGM Biosciences Inc 0.23%
2021-12-31 Immunovant Inc 0.23%
2021-12-31 Scholar Rock Holding Corp 0.23%

投资模拟

公告&资料